• About
  • Blog
  1. Home
  2. Blog
  3. Companies
  4. ANIP

ANI Pharmaceuticals, Inc.(ANIP)

NASDAQ Global Market
Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic
ANI Pharmaceuticals, Inc. logo

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; and potent products, as well as performs contract development and manufacturing of pharmaceutical products for other companies. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, and group purchasing organizations. The company was incorporated in 2001 and is headquartered in Baudette, Minnesota.

Latest News & Analysis

ANI Pharmaceuticals: Strategic growth and market dynamics analysis for 2025. Insights for investors and analysts.
Feb 20, 2025

ANI Pharmaceuticals, Inc. Announces Major Business Developments | Latest Industry News

A comprehensive intraday update on ANI Pharmaceuticals, Inc. (ANIP), covering recent developments, market performance, and strategic initiatives.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.